Dr. Edgardo S. Santos, MD

Dr. Santos practices at The Oncology Institute of Hope and Innovation - Brandon in Cerritos, California.

Dr. Santos' NPI, 1639260771, was assigned on September 27, 2006. Dr. Santos graduated from Universidad de Panama Faculty of Medicine in 1994. Dr. Santos holds Florida license ME83677.

Dr. Santos' primary practice is The Oncology Institute of Hope and Innovation - Brandon, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 699-3970.

Dr. Santos' primary practice is The Oncology Institute of Hope and Innovation - Brandon in Cerritos, California. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Santos to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santos practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Santos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Santos is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Santos' licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and prostate cancer among the conditions Dr. Santos treats.

CMS data shows 178 Medicare services from Dr. Santos across 5 procedure codes in 2023, for 12 Medicare patients. Medicare paid $7,602 for them. Every service was in an office.

CMS counts 12 Medicare patients who saw Dr. Santos in 2024. The largest group is under 65, with 0 patients. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Santos' median patient age at 73, with 47% women.

In 2024, Dr. Santos wrote 54 Medicare Part D claims for 17 patients. 70% of them were for generic drugs. They cover 9 drugs, with $1,008,216 in total drug cost. In 2022, CMS named 471 claims across 22 drugs.

Dr. Santos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 98 papers to Dr. Santos, published from 2006 to 2025. 2014 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Santos has published most often in Expert Rev Anticancer Ther. Dr. Santos' most frequent co-authors are Luis E. Raez, MD, Christian Rolfo, MD and Michel Velez, MD.

Dmand AI links Dr. Santos to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Santos that name 1 trial.

CMS Open Payments shows 3,419 general payments to Dr. Santos from 96 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. AstraZeneca Pharmaceuticals LP paid the most, $368,135. It also lists 11 research payments totaling $17,105 from 2016 to 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Santos, most recently CMS Stage 1 EHR in 2013.

Dr. Santos graduated from Universidad de Panama Faculty of Medicine in 1994.

Dr. Santos is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.